Evolus, Inc. (EOLS) vs Tilray Brands, Inc. (TLRY)
Evolus, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $603.0M against $519.2M — 1.2× the size. Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against 11.5%. Evolus, Inc. has the higher net margin (−10.9% vs −13.3%) and the lower return on invested capital (−14.5% vs −2.27%). Across the 17 metrics below, Evolus, Inc. leads on 11 and Tilray Brands, Inc. on 6.
Valuation
Profitability
| Metric | EOLS | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.74% | 28.45% | 53.94% |
| Operating margin | (5.90%) | (6.88%) | 0.00% |
| Net margin | (10.85%) | (13.26%) | 0.00% |
| Free cash flow margin | (6.92%) | (10.77%) | 0.00% |
| Return on equity | 138.57% | (7.87%) | (0.40%) |
| Return on assets | (14.40%) | (5.52%) | (3.32%) |
| Return on invested capital | (14.47%) | (2.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack